19 pieces, newest first.
Lyrebird Health, an Australian health-tech start-up, has raised $12 million in its first venture funding round. The round was led by Five V Capital and Octopus Ventures, with…
Napo, a London-based insurtech startup founded in 2021 by Jean-Philippe Doumeng and Ludovic Lacay, has secured £12 million in a Series B funding round led by Mercia Ventures.…
Audiological Science, a London-based company specializing in hearing-related medical technology, has received a £12.4 million investment from YFM Equity Partners. This funding will help the company grow and…
HCRG Care Group confirmed it’s investigating a ransomware attack after the Medusa gang claimed to have stolen over two terabytes of sensitive data—including patient records, employee details, and…
Private healthcare in the UK is booming as more Britons are opting to bypass the long NHS waiting lists by paying for treatment. As a result, private hospital…
Doccla, a health-tech startup that addresses hospital bed shortages with its “virtual bed” technology, has raised £35 million ($46 million) in a Series B funding round led by…
A new app is making travel easier for people with conditions like ADHD, Autism, food intolerances, allergies, and other hidden disabilities. The Rakun Card helps users manage and…
Tempus, a company specializing in genomic testing and data analysis, made a notable entrance on the Nasdaq, with its shares climbing 15% on the first trading day reports…
Amber Therapeutics, a pioneering medical technology startup based in London, has successfully closed a $100 million (£78 million) Series A funding round. This investment aims to accelerate the…
Britain’s healthcare system faces a daunting challenge as several renowned hospitals grapple with operational disruptions following a ransomware cyberattack on a crucial blood transfusion management provider. With prestigious…
Cambridge-based biotech startup Fuse Diagnostics has successfully raised £1.6 million in seed funding to develop its innovative diagnostic platforms designed to test industrial products for pathogens. The…
Cambridge-based drug discovery company CN Bio has successfully closed a $21m (£17m) Series B funding round to further develop its innovative technology, which aims to eliminate the need…
Wobble Genomics, a biotech startup stemming from the University of Edinburgh, has secured £8.5 million in funding for its groundbreaking RNA sequencing technology aimed at accelerating drug development…
